Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Temple Health’s Excellence in Health Equity: CBS3 Segment on Peripartum Cardiomyopathy Features Dr. Deborah Crabbe, Patient and Son; Highlights Temple’s Participation in National REBIRTH Clinical Trial

View All News

A CBS3 segment on peripartum cardiomyopathy featured Deborah L. Crabbe, MD, FACC, FAHA, Professor of Medicine at the Lewis Katz School of Medicine at Temple University; patient Chelsi Svenson-Boyce; and her son Jaxson. Peripartum cardiomyopathy, or PPCM, is a rare, complex heart condition that occurs between the last month of pregnancy and 5 months after delivery and can lead to heart failure. PPCM is more commonly seen in African-American women. Temple is participating in the national REBIRTH clinical trial to investigate medical treatment for PPCM. The trial started after Chelsi was diagnosed with her condition.